Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Northwest Biotherapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?

To: John McCarthy who wrote (60)	8/23/2006 8:52:29 PM
From: zeta1961	Respond to of 760

Wowsa!..John!.Thanks!..I have a coupla projects I can use help <g> Seriously..I really appreciate your digging information up..I checked the link for the 80K grant given to Dr. Lau for the listeria vector and it appears to be a completely different project But..ta-ta-taaaa! This is what they got in 2004 from the same people.. 2004 $500,000 was awarded to Dr Keith Black and Dr John Yu at Cedas Sinai for "A Phase I Trial of Tumor Associated Antigen-Pulsed Dendritic Cell Immunotherapy for Patients with Brain Stem Glioma" , which will pay for the first 2 years of a possible 4 year study. First payment of $100,000 was made. Looks like they're on the installment plan.. 2005 $150,000 milestone payment toward $500,000 grant to Cedar Sinai for "A Phase I Trial of Tumor Associated Antigen-Pulsed Dendritic Cell Immunotherapy for Patients with Brain Stem Glioma" - to start the trial on patients! Previous portion of grant was for creation of the vaccine therapy